Associate Professor of Maternal Health Clinical Trials, Tommy's National Centre for Miscarriage Research & WHO Collaborating Centre, University of Birmingham.
This important preliminary finding that first trimester vaginal micronized progesterone might reduce pre-eclampsia needs exploring in a large, multi-centre clinical trial targeting women at risk of pre-eclampsia.
Delighted to see Prof @arricoomarasamy awarded an OBE in the King’s Birthday Honours.
Prof Coomarasamy received his undergraduate medical education here at Birmingham & has been recognised for research into miscarriage & severe bleeding in childbirth
https://t.co/P2dHAETE8k
ICYMI: The vital findings from the @EmotiveTrial have been published.
It's a major breakthrough, fronted by @arricoomarasamy and @adam_devall.
Read the @NEJM paper: https://t.co/6eqpjo2dKF
Incredibly proud to be a part of this vital work from our researchers @arricoomarasamy and @adam_devall who have reported the findings in @NEJM this week
Today, we’re pleased to launch our new 10-year strategy. It’s inclusive, designed to be courageous & defines who we are as an organisation.
Together, we can stop the heartbreak and devastation of baby loss and make pregnancy and birth safe – for everyone: https://t.co/8DT0f1VeRI
Good news: a new trial to manage postpartum bleeding shows highly promising results. This could represent a major breakthrough in reducing maternal deaths. #HealthForAll
https://t.co/wsolaksh0M
I’m very encouraged by the E-MOTIVE Trial results released today at #IMNHC2023 to treat postpartum hemorrhage, the #1 cause of maternal mortality. This new approach led by @unibirmingham and @WHO could drastically improve women’s chances of surviving childbirth globally. https://t.co/5rLoflpcv0
A milestone moment for ending #PPH.
Honoured to co-moderate #IMNHC2023 panel with HE Dr Jallah -MOH-#Liberia on the release of results of the multi-country randomised E-MOTIVE trial -trial shows 60% reduction by early detection & first response treatment bundle for PPH
@alignmnh
It has been a tremendous effort by everyone involved to get the results of the @EmotiveTrial published so quickly, and the findings presented today at the #IMNHC2023 conference
⚡️Breaking news: results from @EmotiveTrial presented for the 1st time @ #IMNHC2023
PPH is leading cause of maternal health 🌍
We found a 60% reduction in composite outcome: severe PPH, laparotomy for bleeding or death from bleeding
Read more in @nejm https://t.co/JA7S0oNdFa
The package of interventions or E-MOTIVE, incl.:
💟 Detect Early
💟 Uterine Massage
💟 Treat with Oxytocic medicines and Tranexamic acid to contract the womb & stop the bleeding
💟 Give IntraVenous fluid (IV fluid)
💟 Examine and when needed, escalate to advanced care
In a large, cluster-randomized trial involving patients with PPH after vaginal delivery, a multicomponent intervention lowered the risk of severe PPH, laparotomy for bleeding, or maternal death from bleeding. Full results of the E-MOTIVE trial: https://t.co/NjcE4Q1rxM
#IMNHC2023
The large trial involved more than 200,000 women around the world, with 80 hospitals taking part across Kenya, Nigeria, South Africa and Tanzania. It was supported by @gatesfoundation and led by @WHOCCGWH. Read the paper: https://t.co/D2ipXgSpDF
Postpartum haemorrhage affects ~24 million women per year and is the leading cause of #maternalmortality worldwide. This study finds that the condition can be identified and treated quicker by using a low-cost drape to measure blood loss and bundling @WHO recommended treatments.
A 🆕 trial promises a major breakthrough in preventing deaths from postpartum bleeding, which is the leading cause of maternal mortality globally.
Following the intervention, severe bleeding after childbirth was reduced by more than 60%
👉 https://t.co/biuPWOkbys
It's the day before the PPH evidence and consensus meeting with @thelancet! We're so pleased to be welcoming leading experts to @Birminghamdubai to share the latest knowledge on #maternalhealth & #PPH. See you all bright and early! @bIGIdeas_UoB@WHOCCGWH @IMSR_UoB
It was a great honour to receive this @unibirmingham impact award for policy change from @ProfWiddows and @theAliceRoberts for our group's work on progesterone treatment to prevent miscarriage
Dr Adam Devall receiving an award for Outstanding Contribution to Research Impact in Policy Change from the University of Birmingham at our recent research impact awards.
Wonderful day @tommysbham with @arricoomarasamy and his amazing colleagues hearing about the groundbreaking research they’re doing to reduce the number of miscarriages and save more babies’ lives. Another dose of inspiration as I settle in @tommys 😊
We are delighted to share the findings of the @PRISM_trial. The results show that progesterone treatment can prevent #miscarriage in women with early pregnancy bleeding and a history of one or more previous pregnancy losses @Tommys_baby @BhamCTU @IMSR_UoB